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Zonula occludens-1ot tight junction formation plays any role in morula to blastocyst transformation
that is associated with development of polarized trophoblast cells and ﬂuid accumulation. Tight junctions are
a hallmark of polarized epithelial cells and zonula occludens-1 (ZO-1) is a known key regulator of tight
junction formation. Here we show that ZO-1 protein is ﬁrst expressed during compaction of 8-cell embryos.
This stage-speciﬁc appearance of ZO-1 suggests its participation in morula to blastocyst transition. Consistent
with this idea, we demonstrate that ZO-1 siRNA delivery inside the blastomeres of zona-weakened embryos
using electroporation not only knocks down ZO-1 gene and protein expressions, but also inhibits morula to
blastocyst transformation in a concentration-dependent manner. In addition, ZO-1 inactivation reduced the
expression of Cdx2 and Oct-4, but not ZO-2 and F-actin. These results provide the ﬁrst evidence that ZO-1 is
involved in blastocyst formation from the morula by regulating accumulation of ﬂuid and differentiation of
nonpolar blastomeres to polar trophoblast cells.
© 2008 Elsevier Inc. All rights reserved.Introduction
Normal preimplantation embryonic development to the blastocyst
stage is critical to the process of initiation of implantation and
pregnancy. Any defects in the blastocyst lead to defective implantation
and infertility. Considering this crucial role of the blastocyst, it is not
clearly understood how a blastocyst is formed from a morula stage
embryo. Following fertilization of oocytes by sperm, one-cell embryos
undergo successive mitotic cell divisions that direct them to develop
to 2-cell, 4-cell, 8-cell, 16-cell (morula) and 32 or more-cell
(blastocyst) stages. Soon after development of the 8-cell embryo in
the mouse, the blastomeres begin to form junctions with one another,
leading to formation of the morula. The morula then undergoes
differentiation to the blastocyst stage where a ﬂuid-ﬁlled blastocoel
appears within the embryo. The blastocyst stage is a milestone in
embryonic life because it has two distinctive cell lineages and gains
the ability to implant. The outer polar single-celled layer of an early
blastocyst is known as the trophectoderm (TE) that surrounds the
blastocoel and a small cluster of nonpolar cells called the inner cell
mass (ICM). Later, the ICM gives rise to two more cell lineages, the
epiblast and the primitive endoderm (PE) or hypoblast at the late
blastocyst stage. Differentiation of blastomeres is important because
following blastocyst implantation trophoblast cells go on to contributel rights reserved.the fetal components of the placenta, while cells of the ICM and
hypoblast form the fetus and yolk sac (Johnson and McConnell, 2004;
Yamanaka et al., 2006), respectively.
Most of our current knowledge on the mechanism of blastocyst
formation has come from studies performed in mouse embryos. These
studies have revealed that blastocyst formation involves a complex
series of events occurring in a precise temporal sequence. Since
preimplantation stage embryos grow well in deﬁned culture media
made of balanced salt solution outside the reproductive tract, factors
produced by embryos at various stages of their development are
considered to be important for embryos to achieve the blastocyst
stage. Emerging evidence indicates that blastocyst formation occurs as
a result of gradual polarization of certain blastomeres as the 8-cell
stage embryo undergoes compaction and morula stages of their
development (Johnson and McConnell, 2004). Polarization of some
blastomeres is established by junction formation between cells at
their lateral surface (Ziomek and Johnson, 1980; Fleming et al., 2001).
Among these junctions, notables are adherens and tight junctions.
These junctions are made of multi-protein complexes and connect
cells at their lateral surfaces generating a layer of polarized cells that
line cavities and tissues (Farquhar and Palade, 1963).
E-cadherin, an integral membrane component of the adherens
junction, is necessary for formation of the trophectoderm epithelium
since E-cadherin null embryos undergo compaction but fail to form
blastocysts with trophoblast cells. Interestingly, however, E-cadherin
null embryos undergo trophoblast outgrowth in vitro suggesting at
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occurs in E-cadherin null embryos (Larue et al., 1994). The question
then naturally arises as to the contribution of the tight junction in the
formation of a blastocyst with trophectodermal epithelium. Previous
studies have demonstrated that the tight junction is a complex seal
between adjoining epithelial cells. It is considered to be at least
bifunctional: it limits the diffusion of solutes through the paracellular
pathway (barrier function) and maintains epithelial cell polarity
building a fence between the apical and basolateral membranes (fence
function). The integral membrane proteins of the tight junction are
occludin and claudins. The peripheral membrane proteins of tight
junctions are ZO-1, ZO-2 and ZO-3 (Tsukita et al., 2001). Among these
TJ proteins, the temporal and spatial expression patterns of occludin
and ZO-1 have been investigated at different stages of preimplanta-
tion development. While occludin and ZO-1α+ are ﬁrst assembled at
cell–cell membrane contact sites between blastomeres in the late
morula stage (Sheth et al., 1997, 2000), ZO-1α− is initially noted as
punctate sites at the cell–cell contacts of compacted 8-cell stage
embryos (Fleming et al., 1989; Sheth et al., 1997). The timing of
occludin and ZO-1α+ expression in latemorulae indicates that they are
probably involved in the ﬁnal events of morula to blastocyst formation
(Sheth et al., 1997, 2000). Preimplantation embryos devoid of occludin,
ZO-2 or ZO-3 developed normally to the blastocyst stage suggesting
that this protein is dispensable for morula to blastocyst transforma-
tion (Saitou et al., 2000; Adachi et al., 2006; Xu et al., 2008). However,
there is no functional study to showwhether or not ZO-1 is needed for
blastocyst formation.
To study the importance of ZO-1 during the time of blastocyst
formation we report the knock-down of endogenous ZO-1 gene
expression in late-stage mouse embryos using small interfering RNAs
(siRNA) against ZO-1. When early 8-cell embryos were electroporated
with ZO-1 siRNAs, these embryos developed to the morula stage with
reduced or no expression of membranous ZO-1 protein but did not
undergo blastocyst formation within 24 h of culture. These results
suggest that ZO-1 protein may be necessary to maintain the integrity
of the trophectoderm layer that is essential for cellular and ﬂuid
compartment formation in blastocysts.
Materials and methods
Animals
Adult male and female CD-1 mice were purchased from Charles River Laboratories
(Wilmington, MA). They were kept in a light–dark cycle (14 h light:10 h dark) in the
Laboratory Animal Facility of Vanderbilt University (Nashville, TN) with unlimited
access to water and food according to the Institutional guidelines on the care and use of
laboratory animals.
Embryo collection and culture
Female mice were paired overnight with fertile males of the same strain. Finding of
a copulation plug the following morning indicated the 1st day (day 1) of pregnancy.
Preimplantation embryos from 2-cell to blastocyst stages [2-cell (day 2 at 0900 h from
oviducts); 4-cell (day 3 at 0300 h from oviducts); 8-cell (day 3 at 1030 and 1300 h from
oviducts); early morula (day 3 at 1800 from oviducts), late morula (day 4 at 0100 h from
oviducts and uteri) and blastocysts (day 4 at 0900 h from uteri)] were collected by
ﬂushing oviducts and uteri (Paria et al., 1993) with potassium simplex optimized
medium with amino acids (KSOMaa) (Lawitts and Biggers, 1991). All medium
components were purchased from Sigma (St. Louis, MO) unless stated otherwise.
Embryos were cultured in groups of 6–10 in microdrops (25 μl) of KSOMaa under silicon
oil in a humidiﬁed atmosphere of 5% CO2/95% air at 37 °C (Paria and Dey, 1990).
Optimization of mouse embryo electroporation (EP) parameters
We ﬁrst standardized the method of electroporation using the cell fusion
instrument (BTX, ECM 2001; San Diego, CA) that can effectively introduce siRNA inside
a zona-encased embryo. Since the normal embryo is protected by zona pellucida, we
decided to use the siPORT™ (AM8990 or AM8990G; Ambion, Austin, TX) as an
electroporation buffer because this buffer is developed for transfecting siRNA into hard-
to-transfect cells and has components to ensure high cell viability and enhanced
delivery of siRNAs. Using this buffer, we next standardized the electroporation
parameters such as voltage, number of pulses, pulse duration and repeats. The embryoswere electroporated in a ﬂat electrode chamber supplied by BTX Inc. The post
electroporation embryo survival rate and developmental potentials were chosen as the
end-point measurements. First, we determined the DC voltage (DCV) requirement for
electroporation using 2-cell and 8-cell embryos by passing a series of DC voltage (from
20–100DCVwith 10 V intervals)while setting the 1ms pulse length,1 pulse number and
0 repeats. In our initial studies we used 2-cell stage embryos to test the electroporation
instrument because previous reports havedemonstrated that application of electricﬁeld
causes blastomere fusion at the 2-cell stage (Cheong et al., 1991). Based on the over 50%
embryo survival rate and blastocyst formation rate of cultured electroporated embryos,
an optimized DCV was selected for testing other electroporation parameters (i.e. pulse
length, pulse number and repeats). We next established other electroporation
parameters keeping DCV unchanged. After repeated trials, we optimized an electro-
poration condition (DC 20 V; 1 ms, 3 pulses, 0 repeat) that we later applied to examine
the incorporation of siRNA in zona weakened 2- and early 8-cell embryos using
Silencer®Cy3-labeled negative siRNA control #1 (Cat. no. 4621; Ambion). Following
electroporation, the embryos were cultured in vitro in KSOMaa and checked for their
survival and the presence of Cy3 ﬂorescence inside blastomeres at 24 h intervals.
Embryo electroporation with custom siRNA
Freshly collected early 8-cell stage embryoswerewashed thoroughly and incubated
≈10–12 s in prewarmed acid Tyrode's solution (T1788, Sigma) to weaken the zona
pellucida (Grabarek et al., 2002) rather than remove it. These embryos were then
transferred to and kept in the pre-made KSOMaa drops in a Petri dish covered with
silicon oil. At the same time, the cell fusion instrument was turned on and siRNA stocks
were diluted in siPORT™ electroporation buffer (AM8990 or AM8990G; Ambion) before
electroporation. While Silencer® negative control #1 (Cat. no. 4611; Ambion) was used
as siRNA control, the blank siPORT™ electroporation buffer was used as electroporation
control. The negative control siRNA is comprised of a 19 bp scrambled sequence with 3′
dt overhang. These sequences have no signiﬁcant homology to any known gene
sequences of mouse, rat or human and have no non-speciﬁc effects on gene expression
(information provided by the Ambion Company).
The custom-made ZO-1 siRNA (mouse; Cat. no. sc-29832; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) were ﬁrst prepared as a stock solution according to the instructions
provided by themanufacturer, and kept at −20 °C. Right before electroporation, the ZO-1
siRNA was diluted into different concentrations in siPORT™ electroporation buffer. A
suitably sized drop of the diluted siRNA solutionwas added between the two electrodes
ﬁxed in an electroporation chamber. The embryos were linearly arranged in the
chamber so that they were equidistant between the two electrodes with about equal
space interval between the two neighboring embryos. A series of direct electrical square
pulses (i.e. 20 DC voltage/1 ms pulse length/3 pulses/0 repeats) were given to the
embryos. After electroporation, the embryoswerewashed and cultured in fresh KOSM-aa
media. Approximately 2 h after electroporation, embryos were observed for their
survival under a Nikon SMZ800 stereo microscope. All apparently non-degenerating
embryos were cultured in vitro for 24 h to 48 h to study their subsequent development.
Experiments were repeated several times and stages of embryonic development were
checked at 24 h intervals and photographed. A group of electroporated embryos after
culture for 24 h were processed for immunoﬂuorescence staining for ZO-1 and
E-cadherin protein expression.
Determination of cell number
Embryos from each treatment group were treated at the end of each experiment
with DAPI (4′, 6′-diamidino-2-phenylindole; 10 μg/ml) for 30 min at room temperature
in a humidiﬁed chamber. Following DAPI treatment, embryos were washed with
phosphate-buffered saline (PBS), mounted onto glass slides and examined under a
ﬂuorescence microscope.
Immunoﬂuorescence detection of E-cadherin, ZO-1, ZO-2, Caudal-related homeobox 2
(Cdx2), POU-family transcription factor, Oct-4, and ﬁlamentous-actin (F-actin) in embryos
The primary antisera used included a rat monoclonal E-cadherin antibody, a
generous gift from Dr. Rolf Kemler, Max-Planck-Institut for Immunbiologie, Freiburg,
German), a rabbit polyclonal ZO-1 antibody (Cat. no. 61-7300, Zymed Laboratories
Inc.) that detects ZO-1α− and ZO-1α+ isoforms, a rabbit polyclonal anti-ZO-2 (Cat. no.
71-1400, Zymed Laboratories Inc.), a mouse monoclonal anti-Cdx2 (Cat. no. MU-
392A-UC, BioGenex), and a goat polyclonal anti-Oct-4 (Cat. no. SC-8628, Santa Cruz
Biotechnology). Embryos were ﬁrst ﬁxed in 4% paraformaldehyde in PBS containing
0.2% BSA for at least 30 min and washed twice in fresh PBS. Fixed embryos were
then permeabilized (PBS with 0.25% Tween-20 and 0.1% BSA), washed and incubated
with primary antisera (ZO-1, 1:150 dilution; ZO-2, 1:150; E-cadherin, 1:100; Cdx2,
1:60; Oct-4, 1:60 dilutions) overnight at 4 °C in a humidiﬁed chamber. At the end of
incubation, embryos were washed 3 times to remove excess primary antibodies and
incubated again with TRITC conjugated goat anti-rabbit IgG or TRITC-conjugated goat
anti-rat IgG or FITC-conjugated secondary antibodies for 1 h at room temperature.
Texas red-labeled phalloidin (Cat. no. T-7471, Molecular Probes) was used for F-actin
staining. Embryos were next washed with fresh PBS 3 times; the ﬁrst wash contained
DAPI for nuclear staining. Non-speciﬁc staining was determined by processing
embryos as described above in the absence of primary antiserum. Embryos were
mounted on a glass slide with Fluoro G to prevent photobleaching and were sealed
with nail polish. The localization of all proteins was visualized under either a Nikon
Fig. 1. ZO-1 protein expression is stage-speciﬁc in developing mouse embryos freshly collected from the reproductive tracts during preimplantation period of pregnancy. All images
(40×) are representative of at least three experiments. A) The localization of ZO-1 (TRITC-labeling) was observed in cell–cell contact sites starting from compacted 8-cell stage and
onwards. Membranous localization of this protein is indicatedwith arrow head. The nuclei were stained with DAPI. Stages of preimplantation embryos stained for ZO-1 are: 2-cell (a),
4-cell (b), uncompacted 8-cell (c), compacted 8-cell (d), 16-cell (e), 30-cell (f), and blastocyst (g). Blastocysts stained in the absence of primary antibody are shown in picture h. B)
Optical sections showed localization of ZO-1 in cell-cell contact sites of a compacted 8-cell stage embryo (a) and blastocyst (b). TE, Trophectoderm; ICM, Inner Cell Mass.
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115H. Wang et al. / Developmental Biology 318 (2008) 112–125Eclipse TS100 microscope equipped with X-Cite 120 for ﬂuorescence and a DigiFire
camera for photography or a Zeiss Axiovert 200 microscope equipped with ApoTome
optical sectioning and appropriate ﬁlters.
RNA extraction, reverse transcription (RT) and quantitative real-time polymerase
chain reaction
Total RNA was extracted from pooled embryos (10 embryos/group) from each
treatment group [control scramble siRNAand threedosage (400,800 and1200nM)of ZO-1
siRNAs] using a previously described protocol (Paria et al., 1993). Brieﬂy, total RNA was
preparedusing sodiumdodecyl sulphate/phenol/chloroformbuffers after addition of E. coli
rRNA (20 μg) as a carrier in each tube. Total RNA equivalent to two and half embryos from
each group was subjected to reverse transcription for complementary DNA synthesis with
SuperScript III RT using random hexamers according to the manufacturer's protocol
(Invitrogen). The primer pairs used for PCR are as follows: 5′-TTCAAAGTCTGCAGAGACAA-
TAGC-3′ (forward) and 5′-TCACATTGCTTAGTCCAGTTCC-3′ (reverse) for ZO-1; 5′-
CCATGGGCGCGGACTATCTGA-3′ (forward) and 5′-CTGTGGCGGGGAGGTTTGACTTG-3′
(reverse) for ZO-2, and 5′-GCTTGCTGGTGAAAAGGACCTCTCGAAG-3′ (forward) and 5′-
CCCTGAAGTACTCATTATAGTCAAGGGCAT-3′ (reverse) for hypoxanthine–guanine phos-
phoribosyl transferase 1 (hprt1), a house-keeping gene (Mamo et al., 2007). Each primer
pair was validated by performing electrophoresis and melting temperature analysis of the
PCR product to ensure the correct size of PCR product and the absence of primer dimers.
Standard concentration curves were also done for each primer pair used. All samples were
run in triplicate fromat least 3 independent experiments. All PCRexperimentswere carried
out using an iQ™5 Real-time PCR Detection System (Bio-Rad Laboratories, Hercules, CA)
with SYBR Green detection. 40 cycles of a two-step PCR sequence were performed, and
critical threshold values (CT) were measured for each sample (Benjamin et al., 2007).
Expression levels of target genes in each sample were compared to hprt1. Differences in
expression between each group were compared by one-way ANOVA and Tukeys post-hoc
analysis. Fold-change for each gene was calculated using the 2−ΔΔCT method.
Statistics
Each experiment was repeated at least three times and results were reported as
mean±S.E.M. For each treatment within an experiment, more than 8 high quality
embryos were used. The data were ﬁrst tested for signiﬁcant differences by ANOVA and
later signiﬁcant differences among multiple treatment groups were determined by
Least Squares Means test. The signiﬁcance level was set at pb0.05.
Results
Expression of ZO-1 and E-cadherin proteins in 2-cell to blastocyst stages
of mouse embryos
We ﬁrst examined stage-speciﬁc embryonic ZO-1 protein expres-
sion by immunoﬂuorescence staining from the 2-cell to the blastocystFig. 2. E-cadherin is localized at cell–cell contact sites in all developing stages of mouse em
pregnancy. Membranous localization of this protein (TRITC-labeling) is indicated with arrow
stained with DAPI. Stages of preimplantation embryos stained for E-cadherin are: 2-cell (a),
primary antibody are shown in picture f. TE, Trophectoderm; ICM, Inner Cell Mass.stage. In a parallel set of experiments using embryos from the same
batch, E-cadherin protein localization was also performed as a marker
of epithelial adherens junctions. ZO-1 expression was not observed in
the 2-cell (Fig. 1Aa) and 4-cell (Fig. 1Ab) stage embryos even though
clear membranous localization of E-cadherin was observed at these
embryonic developmental stages at their cell–cell contact sites (Figs. 2a
and b). ZO-1 expression was ﬁrst observed at the 8-cell stage embryos.
However, not all the 8-cell stage embryos showed ZO-1 expression.
While early uncompacted 8-cell embryos showed no expression (Fig.
1Ac), late compacted 8-cell embryos ﬁrst exhibited punctate accumula-
tion of ZO-1 in cell–cell contactingmembranes (Fig.1Ad). This punctate
localization of ZO-1 in cell–cell contact sites betweenblastomeres of the
8-cell stage embryos was also conﬁrmed by high resolution optical
sections of embryos (Fig. 1Ba). Once ZO-1 started to accumulate in the
cell membrane, its localization continued and strengthened in the 16-
cell stage (Fig. 1Ae), late morula (Fig. 1Af) and blastocyst stages (Figs.
1Ag and Bb). No speciﬁc immunoreactivity was observed when
blastocysts were incubated with secondary antibody in the absence of
primary antibody (Fig. 1h). Similar patterns of ZO-1 localization were
also previously demonstrated (Fleming et al., 1989; Sheth et al., 1997).
Strong membranous E-cadherin protein localization persisted in the 8-
cell stage (Fig. 2c), morula (Fig. 2d) and blastocyst (Fig. 2e) stages of the
embryo. Blastocysts incubated with secondary antibody in the absence
of primary antibody showed no speciﬁc immunostaining (Fig. 2f). This
analysis revealed that while E-cadherin was present in all develop-
mental stages of the preimplantation embryo, ZO-1 was expressed
only during the late 8-cell stage and onwards. Based on this stage-
speciﬁc ZO-1 expression pattern, the morula to blastocyst conversion
event seems to be a unique model to study the role of this protein in
cellular differentiation process during preimplantation embryonic
development.
We next studied ZO-1 function by suppressing ZO-1 expression
using RNA interference technology that has been widely used for the
analysis of gene function in plants, invertebrates andmammalian cells
(Sharp, 2001; Hannon, 2002). Recently, this technique has been
applied in mouse embryos to study the role of speciﬁc gene function
in preimplantation embryonic development (Wianny and Zernicka-
Goetz, 2000; Grabarek et al., 2002; Haraguchi et al., 2004; Soares et al.,
2005). In most of these studies, siRNAs were microinjected at thebryos freshly collected from the reproductive tracts during preimplantation period of
head. All images (40×) are representative of at least three experiments. The nuclei were
4-cell (b), 8-cell (c), morula (d) and blastocyst (e). Blastocysts stained in the absence of
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(Grabarek et al., 2002) demonstrated an electroporation technique to
introduce siRNA in later stages of the preimplantation embryo. Based
on their technique, we ﬁrst attempted to establish electroporation
conditions for zona-weakened 2- and 8-cell embryos using control
Cy3-labeled siRNA. Use of Cy3-labeled siRNA offered the advantage
that incorporation of Cy3 can be visualized under a ﬂuorescence
microscope which will conﬁrm incorporation of siRNA inside each
blastomere.Fig. 3. A) The level of autoﬂuorescence in various stages of embryonic development when
detected using the ﬁlter that was used to visualize Cy3- or TRITC-color. The embryonic stages
level in various stages of embryonic development when 2-cell embryos were electroporated w
cell (a), fused 2-cell (b), 4-cell (c), 8-cell/morula (d), and blastocyst (e). C) Cy3 ﬂuorescence le
with Cy3-labeled control siRNA and cultured for 48 h. a, autoﬂuorescence level in 8-cell em
electroporationwith Cy3-labeled control siRNA; c and d, Cy-3 ﬂuorescence level in in vitro gr
embryos with Cy3-labeled control siRNA. TE, Trophectoderm; ICM, Inner Cell Mass.Set up of electroporation conditions for siRNA incorporation into
preimplantation embryos
In a series of trials, we determined the optimal parameters for
electroporating Cy3-labeled control siRNA (10 μM) ﬁrst in zona-
weakened 2-cell stage embryos. The parameters for optimal electro-
poration were ﬁxed at three 1 ms pulses, each of DC 20 V. Following
electroporationwithout or with control siRNA, embryos were cultured
for72h to theblastocyst stage tomonitorconsequencesof electroporation2-cell embryos were only electroporated and cultured for 72 h. Autoﬂuorescence was
(40×) are: 2-cell (a), 4-cell (b), 8-cell/morula (c), and blastocyst (d). B) Cy3 ﬂuorescence
ith Cy3-labeled control siRNA and cultured for 72 h. The embryonic stages (40×) are: 2-
vel in the 8-cell, morula and blastocyst stages when 8-cell embryos were electroporated
bryos prior to electroporation; b, Cy3 ﬂuorescence level in 8-cell stage embryos after
ownmorula and blastocyst stages, respectively, following electroporation of 8-cell stage
Fig. 4. A) Embryonic survival rate following electroporation (EP) of 8-cell stage embryos
in the presence or absence of control and ZO-1 siRNAs. The numbers on top of each bar
indicate the number of embryos survived/number of embryos electroporated. Number
within the parenthesis indicates number of experiments. Vertical bars indicate the S.E.
M. ZO-1 siRNAs were used at three concentrations, 400, 800 and 1200 nM. Control
siRNA was used at only 1600 nM. Statistical comparisons were made by ANOVA and
Least Square Means test (*pb0.05). B) Incidence of blastocyst formation after
electroporation of ZO-1 siRNA into 8-cell stage embryos. The numbers on top of each
bar indicate the number of blastocysts developed/number of embryos survived after
electroporation. Number within the parenthesis indicates number of experiments.
Vertical bars indicate the S.E.M. ZO-1 siRNAs were used at three concentrations, 400,
800 and 1200 nM. Control siRNA was used at only 1600 nM. Statistical comparisons
were made using ANOVA followed by Least Squares Means test (*pb0.05). C) Effects of
ZO-1 siRNA on blastomere number in the morula stage embryo. After termination of
culture, morulae were stained with DAPI for the purpose of counting blastomere
numbers. Number within the bar indicates number of morulae used to determine
blastomere number. Vertical bars indicate the S.E.M. Statistical comparisons were made
using ANOVA followed by Least Squares Means test (*pb0.05).
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stages of these developing embryos in culture. The majority of
embryos in both groups [electroporation without (33/37; 89%) and
with (39/46; 85%) control siRNA] undergo normal development to the
blastocyst stage. The embryos that were subjected to electroporation
alone exhibited low levels of autoﬂuorescence at any stage of their
subsequent development to the blastocyst stage. In Fig. 3A the level of
autoﬂuorescence in various stages of embryonic development is
shown when 2-cell embryos were only electroporated and cultured
for 72 h. In contrast, strong Cy3 ﬂuorescence was detected in 2-cell
stage embryos right after electroporation (Fig. 3Ba) of Cy3 labeled
control siRNA. This electroporation procedure also resulted in fusion
of blastomeres in some of the 2-cell stage embryos (Fig. 3Bb) showing
the efﬁcacy of application of electric ﬁeld as demonstrated earlier
(Cheong et al., 1991). These embryos also showed strong Cy3
ﬂuorescence (Fig. 3Bb). However, a gradual decrease in intensity of
the Cy3 ﬂuorescence was apparent with the progression of the
embryonic development [4-cell (Fig. 3Bc); 8-cell/morula (Fig. 3Bd);
blastocyst (Fig. 3Be)]. In subsequent experiments, these electropora-
tion parameters when applied to the zona-weakened early 8-cell stage
embryos resulted in successful incorporation of Cy3-labeled control
siRNA inside embryos (Fig. 3C). The 8-cell stage embryos that were
subjected to electroporation alone showed low levels of autoﬂuores-
cence following the procedure (Fig. 3Ca). In contrast, Cy3 ﬂuorescence
was strong in the 8-cell stage embryos following electroporation of
embryos with Cy3-labeled control siRNA (Fig. 3Cb). These embryos
from both groups when cultured in vitro for 24 h developed normally
to the stage of either morulae or blastocysts. These embryos still
displayed Cy3 ﬂuorescence but with reduced levels (Figs. 3Cc and d).
Through these ﬁndings, we understood that siRNA concentration is
not maintained at same level inside the embryo for a long period of
time. However, the above described results also indicate that this
control RNA is not toxic to the embryo because the majority of these
embryos when cultured in vitro developed to the blastocyst stagewith
no visible abnormality.
Based on the preliminary success with control siRNA incorpora-
tion, we proceeded to examine efﬁcacy of ZO-1 siRNA in suppression
of ZO-1 protein expression and the process of morula to blastocyst
transformation.
Deferred blastocyst formation from early 8-cell stage embryos in
presence of ZO-1 siRNA
Zona-weakened early 8-cell stage embryos were electroporated
with custom made ZO-1 siRNA mixture (mixture of three siRNA
created against mouse ZO-1 sequences) at three concentrations (0.4,
0.8 and 1.2 μM). Following electroporation, embryos were initially
cultured in vitro for 2 h to examine their survival. As expected, we
observed that roughly 93% (90–95%) of these electroporated embryos
in all groups showed no sign of noticeable degeneration under a stereo
microscope (Fig. 4A). Morphologically normal embryos were then
cultured in vitro for an additional period of 24 h and their
developmental stages were recorded at the end of the culture.
As shown in Fig. 4B, ZO-1 siRNA reduced the percentage of
blastocyst formation from 8-cell stage embryos after 24 h of culture in
a dose-dependent manner. ZO-1 siRNA at 400–1200 nM concentra-
tions signiﬁcantly decreased the percentage of blastocyst formation
compared to control groups where 8-cell embryos were electro-
porated with or without control siRNA. Almost 69–80% of 8-cell
embryos reached the blastocyst stage in control groups in the absence
or presence of high concentration (1600 nM) of control siRNA. Under
our culture conditions, the percentage of 8-cell embryos that
developed into blastocyst in the control siRNA group (69%, 44/64)
was slightly lower, but insigniﬁcant (pN0.05), compared to the
electroporation alone control group (80%, 45/56). In contrast, when
8-cell embryos were electroporated with the lowest concentration(400 nM) of ZO-1 siRNA, only 34% (19/56) of embryos developed into
blastocysts. The percentage of blastocyst formation further declined
with the increase in concentrations of ZO-1 siRNA for electroporation;
14% (8/56) at 800 nM and 4% (2/45) at 1200 nM (Fig. 4B). Most of the
embryonic developmental arrest in ZO-1 siRNA-treated groups
occurred at later than the 8-cell stage. Cell numbers of these
developmentally arrested embryos were inversely linked with the
118 H. Wang et al. / Developmental Biology 318 (2008) 112–125increasing concentrations of the ZO-1 siRNAs (Fig. 4C). Morulae that
developed from 8-cell embryos in control groups without or with
control siRNAs had an average of 20–30 blastomeres (Fig. 4C). In
contrast, morulae formed in ZO-1 siRNA-treated groups had decreased
number of blastomeres compared to control groups (Fig. 4C). The
average number of blastomeres in morulae formed in the ZO-1 siRNA
electroporated groups was approximately 21, 12 and 11, respectively,
at 400, 800 and 1200 nM concentrations (Fig. 4C). These defects were
considered signiﬁcant and reproducible. The embryonic develop-
mental stages and their morphological appearances after 24 h of
culture in the presence or absence of control siRNA and various
concentrations of ZO-1 siRNA are presented in Fig. 5. While most of
these embryos in all groups lookmorphologically normal under visual
inspection, a few embryos from highest concentration of ZO-1 siRNA
(Fig. 5) showed some sign of degeneration.Fig. 5. Electroporation (EP) of ZO-1 siRNA into 8-cell stage embryos perturbs the developmen
are presented. The 8-cell stage embryos were electroporated with buffer [EP control] (a), c
1200 nM (e).ZO-1 siRNA down-regulates ZO-1, but not ZO-2, gene expression
To assess the efﬁciency of our approach that ZO-1 siRNA
speciﬁcally down regulates ZO-1 gene expression, we performed
Real-time PCR to quantify ZO-1 and ZO-2 mRNA levels in ZO-1 siRNA-
treated (400, 800 and 1200 nM) embryos. Control embryos were
electroporated with a negative scrambled siRNA. As shown in Fig. 6,
ZO-1 siRNA decreased ZO-1, but not ZO-2, mRNA levels compared to
control siRNA-treated group. The level of ZO-1 mRNA at the lowest
concentration of ZO-1 siRNA (400 nM) was not signiﬁcantly different
from the control siRNA-treated group. However, signiﬁcant (pb0.05)
reduction in ZO-1 mRNA levels was observed at 800 nM and 1200 nM
concentrations of ZO-1 siRNA as compared to the control siRNA-
treated group. No signiﬁcant (pN0.05) change in ZO-2 gene expression
level was noticed among embryos electroporatedwith control or ZO-1t of embryos. Photographs (20×) of representative embryos for each experimental group
ontrol siRNA (b), and ZO-1 siRNA at three concentrations, 400 nM (c), 800 nM (d) and
Fig. 6. ZO1 siRNA inhibits ZO-1 gene expression but has no effect on ZO-2 expression.
RNA was isolated from embryos treated with three concentrations of ZO-1 siRNA (400,
800 and 1200 nM). Control embryos were treated with negative sequence siRNA. Gene
expression was measured by Real-time PCR, expressed as fold-change (mean±S. D.),
and normalized to control. Control siRNA (ctrl) was used at only 1600 nM. Statistical
comparisons were made using ANOVA and Tukeys post hoc analysis (*pb0.05, n=3).
Dotted line indicates 100% of control.
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gene expression in embryos.
ZO-1 siRNA speciﬁcally suppresses ZO-1 protein expression in embryos
Analysis of ZO-1 expression by immunoﬂuorescence showed that
ZO-1 is strikingly suppressed in embryos 24 h after electroporation
with ZO-1 siRNA (Fig. 7A). The ZO-1 siRNA-treated embryos showed
either complete or partial loss of ZO-1 immunolabeling from the
cell membrane (Fig. 7A). The morula stage embryos developed from
the control siRNA-treated group showed clear circumferential ZO-1
labeling (Figs. 7Aa and b). The morula stage embryos at lowest
concentration (400 nM) of ZO-1 siRNA showed either partial or
complete loss of ZO-1 localization from the membrane (Figs. 7Ac and
d). Embryos electroporated with 800 and 1200 nM ZO-1 siRNA
showed almost complete absence of ZO-1 immunolabeling from the
cell surface [800 nM (Figs. 7Ae and f) and 1200 nM (Figs. 7Ag and h)].
To conﬁrm the speciﬁcity of ZO-1 knock down using these ZO-1
siRNAs, we analyzed the distribution of E-cadherin proteins in some
of these ZO-1 siRNA electroporated embryos at the same time point at
which we observed ZO-1 knockdown. ZO-1 knockdown apparently
has no effect on E-cadherin expression (Fig. 7B). Membranous E-
cadherin localization was observed in embryos obtained from all
treatment groups regardless of their developmental stages (Fig. 7B).
In a separate study, we performed ZO-1 and E-cadherin double
immunoﬂuorescence staining in the same embryos obtained from all
treatment groups. Individual and combined images of ZO-1 (green)
and E-cadherin (red) double immunoﬂuorescence staining are shown
in Fig. 8. This analysis also revealed that while E-cadherinwas present
in morulae obtained from all treatment groups, ZO-1 was only ex-
pressed in morulae obtained from control siRNA group. These results
are not surprising since adherens junction formation does not depend
on tight junction formation (Gumbiner et al., 1988).
In an additional set of experiments, we attempted to determine the
effects of ZO-1 downregulation on the expression and distribution of
ZO-2, another tight junctional protein (Tsukita et al., 2001), F-actin, a
constituent of the cytoskeleton (Claessens et al., 2006), and two
known transcription factors, Cdx2 and Oct-4, involved in lineage
speciﬁcation in early embryos (Niwa et al., 2005). Immunolocalization
of ZO-2, F-actin, Cdx2 and Oct-4 in vivo grown morulae and
blastocysts were shown in Figs. 9A, 10A and 11A, respectively.
Membranous localization of ZO-2 (Fig. 9A) and F actin (Figs. 9A, 10A
and 11A) was observed in both the in vivo grown morula andblastocyst stages. The majority, but not all, blastomeres of the morula
showed nuclear localization of Cdx2 (Fig. 10Aa). Unlike Cdx2, Oct-4
(Fig.11Aa) stainingwas noted in nuclei of all blastomeres at themorula
stage. While Cdx2 expression was largely observed in nuclei of the
outside blastomeres (Fig. 10Ad), Oct-4 was mainly expressed in nuclei
of blastomeres of ICM, at the blastocyst stage (Fig. 11Ad). However, a
few nuclei of trophoblast cells of the blastocyst still showed the low
level of Oct-4 expressions (Fig. 11Ad). These expression patterns of
Cdx2 and Oct-4 are consistent with the previous argument that these
two transcription factors play a major role in the segregation of two
cell lineages, the ICM and TE, during blastocyst formation (Niwa et al.,
2005). We considered that downregulation of ZO-1 expression could
effect the expression of Cdx2 and Oct-4, but not ZO-2 and F-actin. We
used only the morula stage embryos from control siRNA and two
dosages of ZO-1 siRNA electroporated groups since it was not possible
to obtain blastocysts after electroporation of ZO-1 siRNAs. In control
electroporation group, we noted normal expression of ZO-2 (Figs. 9Ba
and c), F-actin (Figs. 9Bb and c, 10Bb and c and 11Bb and c), Cdx2 (Figs.
10Ba and c) and Oct-4 (Figs. 11Ba and c) in morulae. Likewise, we
observed no change in the pattern of ZO-2 (Figs. 9Bd and f) and F-actin
(Figs. 9Be and f,10Be and f and 11Be and f) localization in control siRNA
electroporated group. In contrast, while ZO-2 expression (Figs. 9Bg
and i) showed no change, the expression of Cdx2 (Figs. 10Bg and i) and
Oct-4 (Figs. 11Bg and i) was considerably reduced in morulae obtained
from the lowest dose of ZO-1 siRNA electroporated group. These
ﬁndings provide evidence that inhibition of ZO-1 expression does not
inﬂuence ZO-2 and F-actin expression and distribution, but decreases
Cdx2 and Oct-4 protein expression.
When a few of these morulae from all groups were cultured for an
additional 24 h (a total period of 48 h), all embryos in control groups
reached the blastocyst stage while a few of the morula stage embryos
showed blastocoel formation in lower doses (400 nM) of ZO-1 siRNA.
The embryos treated with highest concentrations underwent degen-
eration by 48 h (data not presented).
Discussion
The current study was initiated to investigate the presumed
involvement of ZO-1 in the process of 8-cell stage to blastocyst
formation. Given the ﬁrst observed membranous localization of ZO-1
in the 8-cell stage embryos and onwards, ZO-1 associated tight
junction formation is considered to be important for blastocyst
formation. Our results of ZO-1 knockdown and reduction in blastocyst
formation by ZO-1 siRNA revealed an important role of ZO-1 in
initiating blastocyst formation from the morula.
Based on the information accumulated over the years, it is
reasonably clear that gradual formation of ﬁrst adherens and next
tight junctions in the outside cells of the morula help to form the
trophectoderm layer and retention of ﬂuid inside the embryo. Thus,
inhibition of one of these phenomena should inhibit blastocyst
formation. Indeed, E-cadherin knockout embryos fail to develop past
the morula stage (Larue et al., 1994; Ohsugi et al., 1997). However, the
actual role of E-cadherin in early stages of embryonic development
still remained unknown in this model because of residual maternal
transcripts in embryos (Larue et al., 1994). Thus, we wondered
whether tight junction formation in outside cells of the morula is
important for the formation of the trophectoderm and blastocoel. To
address this issue we electroporated early 8-cell stage embryos with
ZO-1 siRNAs to silence ZO-1 expression in later developmental stages.
We found that suppression of ZO-1 did not prevent 8-cell embryos
from undergoing compaction. However, the majority of these
compacted embryos did not reach the blastocyst stage by 24 h. Only
a few embryos in lower dose reached the blastocyst stage with a small
blastocoel. The developmental potential of each embryo appeared to
correlate with the expression pattern of ZO-1. A small percentage of
embryos that had weak expression for ZO-1 may be showing retarded
Fig. 7. A)Electroporationof ZO-1 siRNAat the8-cell stage embryoeffectively suppresses ZO-1expression fromthemorula stage embryos. Photographs (40×) of two representative embryos for
each experimental group are presented. All images are representative of at least three experiments. The nuclei were stained with DAPI. a and b, morula from control siRNA group; c and d;
morulae from 400 nM ZO-1 siRNA group; e and f; morulae from 800 nMZO-1 siRNA group; g and h,morulae from 1200 nMZO-1 siRNA group. B) Electroporation of ZO-1 siRNA at the 8-cell
stage embryo didnot perturb E-cadherin expression from themorula stage embryos. Photographs (40×) of two representative embryos for each experimental group are presented. All images
are representative of at least three experiments. The nuclei were stained with DAPI. a and b, morula from control siRNA group; c and d; morulae from 400 nM ZO-1 siRNA group; e and f;
morulae from 800 nM ZO-1 siRNA group; g and h, morulae from 1200 nM ZO-1 siRNA group.
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culture. However, this study does not provide information how long
siRNA effects can persist. In this regard, it has been demonstrated that
gene silencing by this method in mouse embryos can persist for
several days (Soares et al., 2005). This effect of ZO-1 siRNAs was also
speciﬁc since suppression of ZO-1 did not disturb ZO-2 mRNA
expression and the localization of E-cadherin, ZO-2 and F-actin
proteins in these embryos. In addition, our study also indicates that in
the absence of ZO-1, E-cadherin and ZO-2 might support 8-cell stage
embryos to reach to the compaction stage. If this is the case, it can be
speculated that ZO-1 has its own function in the window of morula to
blastocyst formation. Since ZO-3 knock outmice are normal and fertile
(Adachi et al., 2006) and ZO-2 knock out embryos die shortly after
implantation due to an arrest in early gastrulation (Xu et al., 2008),
ZO-2 and ZO-3 functions in blastocyst formation are dispensable.
However, the function of ZO-1 is unknown at this stage. Our results,
however, suggest that loss-of-function of ZO-1 resulted in decreased
expression of Cdx2 and Oct-4. In this regard, it has been demonstrated
that an interaction between Cdx2 and Oct3/4 determines the ﬁrstdifferentiation event of mammalian development (Niwa et al., 2005).
Collectively, the results suggest that one cause of failure or delay in
morula to blastocyst transformation in ZO-1 siRNA electroporated
embryos is decreased expression of lineage speciﬁc genes Cdx2 and
Oct-4.
This work shows a possible role of ZO-1 in blastocyst formation
but it needs to be placed in context with previous studies in embryos
as well as in various epithelial cell lines. It has been demonstrated in
epithelial cell lines that TJ formation was delayed but not abolished
when ZO-1 was knocked down or abolished (Umeda et al., 2006).
However, suppression of ZO-2 in ZO-1 and ZO-3-deﬁcient cells
successfully stopped TJ formation (Umeda et al., 2006). Since ZO-3 is
not required for TJ formation (Adachi et al., 2006; Umeda et al.,
2006) and possibly not redundant with ZO-1 and/or ZO-2 (Itoh et al.,
1999), the question remains as to the redundancy of ZO-1 and ZO-2.
In this regard, Umeda and coworkers (2006) showed that ZO-1 and
ZO-2 appear to be functionally redundant but they can also
independently determine whether and where claudins are polymer-
ized. In our study, we only suppressed ZO-1 expression but not ZO-2.
Fig. 8. ZO-1 and E-cadherin double immunolabeling in same embryos obtained from the control and ZO-1 siRNA groups. ZO-1 (green) and E-cadherin (red) expression did not alter in
the control siRNA-treated embryos. However, while E-cadherin expression remained undisturbed, ZO-1 expression did not notice in morulae obtained from ZO-1 siRNA-treated
groups. Left panel shows ZO-1 expression (a, d, g, and j). Middle panel shows E-cadherin expression (b, e, h, and k). Right panel shows combined immunostaining of ZO-1 and E-
cadherin (c, f, i, and l). The nuclei were stained with DAPI.
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Fig. 9. Immunolocalization of ZO-2 (green) and F-actin (red) in the same morula and blastocyst stage embryos. A) Morulae and blastocysts were freshly collected from the
reproductive tracts on days 3 and 4 of pregnancy. B) Morulae were obtained after electroporation of controls and one dosage of ZO-1 siRNAs. The nuclei were stained with DAPI.
Membranous localization of these proteins is indicated with arrow head. TE, Trophectoderm; ICM, Inner Cell Mass.
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Fig. 10. Immunolocalization of Cdx2 (green) and F-actin (red) in the same morula and blastocyst stage embryos. A) Morulae and blastocysts were freshly collected from the
reproductive tracts on days 3 and 4 of pregnancy. B) Morulae were obtained after electroporation of control and one dosage of ZO-1 siRNAs. The nuclei were stained with DAPI.
Membranous localization of these proteins is indicated with arrow head. TE, Trophectoderm; ICM, Inner Cell Mass.
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Fig. 11. Immunolocalization of Oct-4 (green) and F-actin (red) in the same morula and blastocyst stage embryos. A) Morulae and blastocysts were freshly collected from the
reproductive tracts on days 3 and 4 of pregnancy. B) Morulae were obtained after electroporation of control and one dosage of ZO-1 siRNAs. The nuclei were stained with DAPI.
Localization of these proteins is indicated with arrow head. TE, Trophectoderm; ICM, Inner Cell Mass.
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125H. Wang et al. / Developmental Biology 318 (2008) 112–125However, we know that occludin ﬁrst assembles in the outer cells of
the late morula when both ZO-1 and ZO-2 are present (Sheth et al.,
2000). This suggests that the occludin/ZO-1 or ZO-2 complexes may
play an important role in TJ formation in outer cells of the morula.
Since the absence of occludin (Saitou et al., 2000), some of claudins
(Furuse et al., 2002; Nitta et al., 2003; Gow et al., 2004), ZO-2 (Xu et
al., 2008) and ZO-3 (Adachi et al., 2006; Xu et al., 2008) does not
affect blastocyst formation, single knockout of ZO-1 or knockout of
ZO-1 and ZO-2 in combination will be required to understand the
deﬁnitive role of these TJ proteins in embryo development and
blastocyst formation. In this regard a recent study (Madan et al.,
2007) has demonstrated that blockage of Na/K-ATPase α1 subunit
expression by microinjecting fertilized 1-cell stage embryos with Na/
K-ATPase β1 siRNA resulted in inhibition of morula to blastocyst
formation by inhibiting Na/K-ATPase β1 protein expression together
with aberrant expression of Na/K-ATPase α1 and tight junction
proteins, ZO-1 and occludin.
The current study is the ﬁrst to assign a function of ZO-1 in the
process of morula to blastocyst conversion. Disruption of ZO-1-
mediated tight junction formation leads to arrest of embryonic
development at the morula stage without further differentiation of
outside and inside cells to the trophectoderm and inner cell mass. It
has been well established that construction of an epithelial layer ﬁrst
requires the formation of cadherin-based adherens junctions that
helps to build later tight junctions (Gumbiner et al., 1988). These two
junctional networks jointly regulate the strength of adhesion between
cells permitting epithelia to meet the functional needs of the tissue.
Our study demonstrates that in the absence of ZO-1, E-cadherin-based
junctions do not provide enough support to the outer cells of the
morula to initiate ﬂuid accumulation inside the embryo.
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